Sucampo's glaucoma drug Rescula wins FDA clearance

12/13/2012 | American City Business Journals

The FDA approved the use of Sucampo Pharmaceuticals' Rescula, or unoprostone isopropyl, for intraocular pressure reduction in patients with ocular hypertension or open-angle glaucoma. Sucampo plans to launch the drug in the first quarter.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN